Armistice Capital »

Rogers Communications -cl B shares owned by Armistice Capital

Quarter-by-quarter ownership of Rogers Communications -cl B (RCI) shares owned by Armistice Capital from 13F filings

Historical chart of Armistice Capital investment in Rogers Communications -cl B

Tip: Access up to 7 years of quarterly data

All positions including Rogers Communications -cl B held by Armistice Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rogers Communications -cl B by Armistice Capital

Quarter filed Position value Share count Share price at filing
2023-09-30 $208k 5.4k 38.39

More positions owned by Armistice Capital

Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Argenx Se Sponsored Adr (ARGX)
Supernus Pharmaceuticals (SUPN)
Ptc Therapeutics I (PTCT)
Neurocrine Biosciences (NBIX)
Agios Pharmaceuticals (AGIO)
Biogen Idec (BIIB)
Colgate-Palmolive Company (CL)
Travere Therapeutics (TVTX)
Nevro (NVRO)
Amazon (AMZN)
Dentsply Sirona (XRAY)
Regeneron Pharmaceuticals (REGN)
Alphabet Cap Stk Cl A (GOOGL)

View all positions for Armistice Capital

Top funds holding Rogers Communications -cl B

Royal Bank of Canada
Bank Of Montreal
Canoe Financial
Beutel, Goodman & Company
TD Asset Management
Mackenzie Financial
Bank of America Corporation
Bank of Nova Scotia
National Bank Of Canada /fi/
Letko, Brosseau & Associates
Goldman Sachs Group
Connor, Clark & Lunn Investment Management
Agf Management
Point72 Asset Management
Scotia Capital

View all funds holding Rogers Communications -cl B